Clinical pharmacology of etoposide in children undergoing autologous stem cell transplantation for various solid tumours
暂无分享,去创建一个
D. Wall | P. Gwilt | T. McGuire | J. Davda | K. Manouilov | G. Baheti | B. Gordon
[1] M. Heyman,et al. Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia – a multicentre study from the Nordic Society of Paediatric Haematology and Oncology , 2015, British journal of haematology.
[2] J. Hainsworth,et al. High-dose etoposide: from phase I to a component of curative therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] J. Palle,et al. Etoposide pharmacokinetics in children treated for acute myeloid leukemia , 2006, Anti-cancer drugs.
[4] Iftekhar Mahmood,et al. Prediction of drug clearance in children from adults: a comparison of several allometric methods. , 2006, British journal of clinical pharmacology.
[5] G. Hale. Autologous hematopoietic stem cell transplantation for pediatric solid tumors , 2005, Expert review of anticancer therapy.
[6] Y. Nieto,et al. Pharmacokinetics of high-dose chemotherapy , 2004, Bone Marrow Transplantation.
[7] N. Sakura,et al. Pharmacokinetics of etoposide with intravenous drug administration in children and adolescents , 2003, Pediatrics international : official journal of the Japan Pediatric Society.
[8] B. Hero,et al. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma , 2002, Bone Marrow Transplantation.
[9] T. Klingebiel,et al. Population pharmacokinetics of high-dose etoposide in children receiving different conditioning regimens , 2002, Anti-cancer drugs.
[10] A. Adjei,et al. The pharmacologic basis of high dose chemotherapy with haematopoietic stem cell support for solid tumours , 2001, British Journal of Cancer.
[11] L. Madero,et al. High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors , 1999, Bone Marrow Transplantation.
[12] P. Gwilt,et al. Assay for etoposide in human serum using solid-phase extraction and high-performance liquid chromatography with fluorescence detection. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[13] S. Feig,et al. Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] F. Berthold,et al. Steady-state levels and bone marrow toxicity of etoposide in children and infants: does etoposide require age-dependent dose calculation? , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] T. Madden,et al. Altered etoposide pharmacokinetics and time to engraftment in pediatric patients undergoing autologous bone marrow transplantation. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] M. Cole,et al. Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation. , 1993, Cancer research.
[17] W. Evans,et al. Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumors. , 1984, Cancer research.
[18] M. Kletzel,et al. Pediatric transplantation: results in solid tumors. , 2005, Current hematology reports.
[19] F. Cavalli,et al. Pharmacokinetics of VP16-213 given by different administration methods , 2004, Cancer Chemotherapy and Pharmacology.
[20] A. Look,et al. Pharmacokinetics of teniposide (VM26) and etoposide (VP16-213) in children with cancer , 2004, Cancer Chemotherapy and Pharmacology.
[21] H. McLeod,et al. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics , 2004, Cancer Drug Discovery and Development.
[22] E N Jonsson,et al. Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. , 1999, Computer methods and programs in biomedicine.
[23] W. Evans,et al. Pharmacokinetics of anticancer drugs in children. , 1983, Drug metabolism reviews.